Complaints of insomnia in the USA 1995-1998: Prevalence, psychiatric comorbidity and pharmacologic treatment patterns

Primary Care Psychiatry

Volumn 7, Issue 4, 2001, Pages 145-151

  Skaer, Tracy L ^a   Sclar, David A ^a   Robison, Linda M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Antidepressant; Comorbidity; Complaint; Depression; Hypnosedative; Insomnia; Na tional Ambulatory Medical Care Survey; Self report

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH SURVEY; HUMAN; INSOMNIA; MALE; MENTAL DISEASE; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SELF REPORT; UNITED STATES;

EID: 0035713711     PISSN: 13552570     EISSN: None     Source Type: Journal    
DOI: 10.1185/135525701753429326     Document Type: Article

References (48)

1. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. I
2. Helping patients who say they cannot sleep: Practical ways to evaluate and treat insomnia
3. Sleep and its disorders
4. Antidepressant treatment of the depressed patient with insomnia
5. Clinical categories of sleep disorders I
6. Public health and insomnia: Economic impact
7. Mental comorbidity of chronic insomnia in general practice attenders using DSM-III-R
8. Prevalence, burden, and treatment of insomnia in primary care
9. Prevalence of DSM-IV diagnostic criteria of insomnia: Distinguishing insomnia related to mental disorders from sleep disorders
10. Sleep and quality of life in the Austrian population
11. Study of insomnia in Europe. Epidemiology of severe insomnia and its consequences in Germany
12. Prevalence of insomnia in a survey of 12,778 adults in France
13. Evaluation of severe insomnia in the general population: Results of a European multinational survey
14. Insomnia
15. Pathophysiology and management of insomnia during depression
16. Insomnia in relation to depression and anxiety: Epidemiologic considerations
17. Comorbidity of mental and insomnia disorders in the general population
18. The diagnosis and management of insomnia in clinical practice: A practical evidence-based approach
19. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?
20. Prodromes and precursors: Epidemiologic data for primary prevention of disorders with slow onset
21. Management of insomnia
22. The morbidity of insomnia uncomplicated by psychiatric disorders
23. Psychiatric comorbidity and pharmacological treatment patterns among patients presenting with insomnia: An assessment of office-based encounters in the USA in 1995 and 1996
24. Sampling design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey. National Center for Health Statistics
25. A reason for visit classification for ambulatory care. National Center for Health Statistics
26. The collection and processing of drug information. National Ambulatory Medical Care Survey, 1980. National Center for Health Statistics
27. Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995
28. Trend in the rate of depressive illness by ethnicity/race. An assessment of office-based visits in the United States 1992-1997
29. The direct economic costs of insomnia in the United States for 1995
30. Daytime consequences and correlates of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. II
31. Quality of life in people with insomnia
32. Consequences of reported poor sleep
33. Sleep problems and their correlates in a working population
34. Ten-year trends in the pharmacological treatment of insomnia
35. Public health and insomnia: Consensus statement regarding its status and needs for future actions
36. Diagnosis and treatment of insomnia and risks associated with lack of treatment
37. Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: An overview of insomnias and related disorders - Recognition, epidemiology, and rational management
38. Drug treatment of insomnia: Indications and newer agents
39. Diagnosis and treatment of insomnia and depression